0001654954-21-010887.txt : 20211007 0001654954-21-010887.hdr.sgml : 20211007 20211007144717 ACCESSION NUMBER: 0001654954-21-010887 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20211007 DATE AS OF CHANGE: 20211007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wendel Bruce CENTRAL INDEX KEY: 0001364846 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40023 FILM NUMBER: 211312193 MAIL ADDRESS: STREET 1: 70 ELEVEN O'CLOCK ROAD CITY: WESTON STATE: CT ZIP: 06883 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 203 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 203 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 section16.xml FORM 4 X0306 4 2020-11-16 0000109657 GT Biopharma, Inc. GTBP 0001364846 Wendel Bruce C/O GT BIOPHARMA, INC. 9350 WILSHIRE BLVD. STE. 203 BEVERLY HILLS CA 900212 true Common Stock 2020-11-16 4 P false 3268 3.14 A 3268 D Common Stock 2020-12-22 4 P false 1374 8.87 A 4642 D Common Stock 2020-12-22 4 P false 441 8.73 A 5083 D Common Stock 2021-02-16 4 A false 347572 0.00 A 352655 D Option to purchase Common Stock 6.33 2021-02-16 4 A false 50000 0.00 A 2031-02-15 Common Stock 50000 50000 D Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022. 1/3rd of the shares vest on February 16, 2021, 2022, and 2023. Bruce Wendel 2021-10-06